T1	Entity 39 42	p21
T2	Entity 47 51	bcl2
T3	Association 98 102	risk
E1	Association:T3 bc:T4 snp_int:T6 snp_int2:T11
T4	Cancer 84 97	breast cancer
T5	Entity 106 118	Saudi Arabia
T6	SNP 0 31	Single nucleotide polymorphisms
R1	SNP_coupled_gene Arg1:T6 Arg2:T1	
R3	Population_assignment Arg1:T6 Arg2:T5	
T7	SNP 129 160	single nucleotide polymorphisms
T8	SNP 162 166	SNPs
R4	Equiv Arg1:T8 Arg2:T7	
T9	Entity 182 185	p21
T10	Entity 189 193	bcl2
T11	SNP 0 31	Single nucleotide polymorphisms
R2	SNP_coupled_gene Arg1:T11 Arg2:T2	
R5	Population_assignment Arg1:T11 Arg2:T5	
T12	SNP 162 166	SNPs
R6	SNP_coupled_gene Arg1:T12 Arg2:T9	
R7	SNP_coupled_gene Arg1:T8 Arg2:T10	
T13	Effect_Type 194 202	increase
T14	Association 203 217	susceptibility
E2	Association:T14 snp_int:T8 snp_int2:T12 bc:T15
A1	Effect_Type E2 Increase
R8	Effect_type_marker Arg1:E2 Arg2:T13	
T15	Cancer 221 234	breast cancer
T16	SNP 288 308	polymorphic variants
A2	SNP_Class T16 Common_variant
T17	SNP 288 308	polymorphic variants
A3	SNP_Class T17 Common_variant
T18	Spec 246 249;267 272	not clear
T19	Effect_Type 332 340	increase
T20	Association 341 345	risk
E3	Association:T20 snp_int:T17 snp_int2:T16 bc:T15
A4	Effect_Type E3 Increase
R9	Effect_type_marker Arg1:E3 Arg2:T19	
T21	Entity 349 362	Saudi Arabian
R10	Population_assignment Arg1:T17 Arg2:T21	
R11	Population_assignment Arg1:T16 Arg2:T21	
R12	Speculation_marker Arg1:E3 Arg2:T18	
T23	SNP 432 445	polymorphisms
T24	Entity 449 452	p21
T25	Entity 456 460	Bcl2
T26	SNP 432 445	polymorphisms
R13	SNP_coupled_gene Arg1:T26 Arg2:T24	
R14	SNP_coupled_gene Arg1:T23 Arg2:T25	
T22	Spec 414 431	determine whether
T27	Association 499 503	risk
E4	Association:T27 snp_int:T23 snp_int2:T26 bc:T29
A5	Effect_Type E4 Increase
T28	Effect_Type 489 498	increased
R15	Effect_type_marker Arg1:E4 Arg2:T28	
R16	Speculation_marker Arg1:E4 Arg2:T22	
T29	Cancer 507 520	breast cancer
T30	Entity 524 535	Saudi women
R17	Population_assignment Arg1:T23 Arg2:T30	
R18	Population_assignment Arg1:T26 Arg2:T30	
T31	SNP 542 550	rs733590
T32	Entity 537 540	p21
A6	SNP_Class T23 Common_variant
A7	SNP_Class T26 Common_variant
A8	SNP_Class T31 Common_variant
R19	SNP_coupled_gene Arg1:T31 Arg2:T32	
T33	Entity 552 553	C
R20	SNP_allele Arg1:T31 Arg2:T33	
T34	Neg 564 567	not
T35	Association 580 590	associated
E5	Association:T35 bc:T36 snp_int:T31 snp_int2:T38
T36	Cancer 596 609	breast cancer
R21	Negation_marker Arg1:E5 Arg2:T34	
R22	Member Arg1:T26 Arg2:T31	
T37	Entity 554 555	T
T38	SNP 542 550	rs733590
R23	SNP_allele Arg1:T38 Arg2:T37	
T39	SNP 542 550	rs733590
T40	Entity 649 669	reverse mutation T/C
T41	Spec 670 678	might be
T42	Association 679 685	linked
E6	Association:T42 bc:T43 snp_int:T39
R24	Speculation_marker Arg1:E6 Arg2:T41	
T43	Cancer 691 704	breast cancer
R25	SNP_allele Arg1:T39 Arg2:T40	
R26	Member Arg1:T26 Arg2:T39	
A9	SNP_Class T38 Common_variant
R27	Member Arg1:T26 Arg2:T38	
T45	SNP 391 396	study
T46	Level 737 747	marginally
T47	Association 748 758	associated
E7	Association:T47 snp_int:T45 bc:T48
A10	Level E7 Low
R30	Level_marker Arg1:E7 Arg2:T46	
T48	Cancer 772 785	breast cancer
T49	Level 835 848	significantly
T50	Association 849 859	associated
E8	Association:T50 bc:T51
A11	Level E8 High
R31	Level_marker Arg1:E8 Arg2:T49	
T51	Cancer 873 886	breast cancer
T53	Entity 722 731	genotypes
T52	Entity 968 970	AA
T54	Entity 975 977	AG
T55	Entity 978 980	GG
T58	SNP 386 390	this
R32	Genotype Arg1:T58 Arg2:T52	
T60	SNP 379 382	aim
T61	Entity 913 914	G
R35	SNP_allele Arg1:T60 Arg2:T61	
T62	Level 919 925	higher
T63	Association 900 909	frequency
E10	Association:T63 snp_int:T60 bc:T64
A12	Level E10 High
R36	Level_marker Arg1:E10 Arg2:T62	
T64	Cancer 936 944	patients
R37	Equiv Arg1:T64 Arg2:T51	
R38	Member Arg1:T53 Arg2:T52	
R39	Member Arg1:T53 Arg2:T54	
R40	Member Arg1:T53 Arg2:T55	
T65	Association 1030 1047	dominant genotype
E11	Association:T65 snp_int:T58 bc:T64
R28	Genotype Arg1:T45 Arg2:T53	
R29	Member Arg1:T23 Arg2:T58	
R33	Member Arg1:T23 Arg2:T45	
R41	Member Arg1:T23 Arg2:T60	
R34	Equiv Arg1:T6 Arg2:T26	
R42	Equiv Arg1:T11 Arg2:T23	
A13	SNP_Class T39 Common_variant
